Fosamax and Other Bisphosphonates: Are They Worth the Risk?

The gap between the prescription and the forum

You left the appointment with a prescription for alendronate and a sense that it was routine. Then you searched the name and found jaw necrosis, femur fractures, and a comment section full of people who swore they would never take it. The gap between "routine" and "never" is where most women get stuck.

This article closes that gap for one drug class only: Fosamax and other bisphosphonates. If you want every osteoporosis medication explained, start with our plain-English guide to osteoporosis medications. Here we go deep on how bisphosphonates work, how rare the scary events actually are, the rules that keep them safe, and who they help most. Nothing here is a reason to skip or stop a prescription. That decision belongs to you and your physician.

How Fosamax and other bisphosphonates work

Your skeleton is constantly rebuilt by two cell types. Osteoclasts remove old bone; osteoblasts lay down new bone. After menopause the removal crew gets ahead, and density drifts down.

Bisphosphonates bind tightly to bone surfaces. When an osteoclast starts dissolving that surface, it takes up the drug and shuts down. Fewer active osteoclasts means less removal, so the builders catch up and the small pits of remodeling fill in. On a DEXA that shows up as a modest rise in density over the first couple of years, then a plateau. That plateau is the drug working: it is holding the line.

Because they bind to bone, bisphosphonates stay in the skeleton long after the last dose, which is why the drug keeps offering some protection during a holiday.

The four bisphosphonates you will hear about

• Alendronate (Fosamax). A weekly tablet, available as an inexpensive generic, and the most studied of the group. The one most physicians reach for first.
• Risedronate (Actonel). A weekly or monthly tablet with a similar profile.
• Ibandronate (Boniva). A monthly tablet or quarterly IV. Its trial evidence is strongest for spine fractures.
• Zoledronic acid (Reclast). A yearly IV infusion that skips the esophagus entirely. The first infusion can bring a day or two of flu-like aches.

Generic alendronate is inexpensive on most plans; check your own coverage.

Are bisphosphonates worth the risk? The two events people fear

Two rare side effects drive most of the fear online, and they deserve a proportional answer.

Osteonecrosis of the jaw

A patch of jawbone that fails to heal, usually after a tooth extraction or other invasive dental work. It was first recognized in cancer patients receiving high, frequent IV doses. At osteoporosis doses it is rare, measured in cases per many thousands of patient-years, and the risk rises modestly the longer you take the drug. The practical steps: finish major dental work before you start when that is possible, keep up regular dental care, and make sure your dentist knows what you take. A routine cleaning or filling is not the concern; extractions and implants are the moments to coordinate.

Atypical femoral fracture

An unusual break in the shaft of the thigh bone, sometimes after minimal trauma, in people on long-term bisphosphonates. It is rare, it tracks with duration, and the risk appears to fall after stopping. It also tends to announce itself: new, persistent aching in the thigh or groin, especially on both sides, is the warning sign to report the same day, because an X-ray can catch a stress reaction before it becomes a fracture.

The proportion

Here is the comparison that puts both in context. The Bone Health and Osteoporosis Foundation (BHOF) estimates that about 1 in 2 women over 50 will break a bone because of osteoporosis. Hip fractures in particular carry a heavy cost in independence. In clinical trials, bisphosphonates reduce spine fractures substantially and reduce hip fractures in women with established osteoporosis. For the women those trials describe, the fractures prevented outnumber the rare events caused by a wide margin. That is the arithmetic behind "worth the risk," and it is also why the arithmetic changes for a woman whose fracture risk was low to begin with.

The esophagus rules, and why they exist

Oral bisphosphonates are famous for their instructions, and the instructions are not fussiness. A tablet that lingers in the esophagus can irritate or ulcerate it, and food, coffee, or other medications block absorption almost completely. So:

1. Take it first thing in the morning, on an empty stomach.
2. Swallow it whole with a full glass of plain water, nothing else.
3. Stay upright, sitting or standing, for at least 30 minutes.
4. Wait before eating, drinking anything else, or taking other medications.

Heartburn, difficulty swallowing, or chest pain after a dose is something to report rather than push through. If you have reflux disease, a hiatal hernia, or trouble staying upright, your physician may steer you toward the yearly infusion or a different class, one of the ways the safest osteoporosis treatment turns out to be an individual answer.

Why physicians talk about drug holidays

Because bisphosphonates stay bound in bone, protection persists for a while after stopping, and because the two rare risks rise with duration, many physicians reassess after 3 to 5 years. If your fracture risk is no longer high, they may pause the drug for a period and monitor with DEXA, then restart if density slips or a fracture occurs. If your risk stays high, they may continue.

Three things to know about holidays. A holiday is prescribed by your physician, based on your T-score, fracture history, and how your bones responded; it is not something to declare on your own. It applies to bisphosphonates specifically, because of how they bind to bone. And it is the opposite of the rule for Prolia (denosumab), which must never be stopped without a physician exit plan, because rebound bone loss and multiple vertebral fractures are documented when it lapses. A physician moving a patient from Prolia to a bisphosphonate is using exactly this property to protect the gains.

Who benefits most from bisphosphonates?

The balance tips most clearly toward treatment when fracture risk is high:

• A prior fragility fracture. A bone that broke from a fall from standing height, or less, is the strongest predictor of the next one.
• A T-score of -2.5 or below at the spine, hip, or femoral neck (the WHO threshold for osteoporosis).
• A FRAX score above the U.S. thresholds of 20% ten-year risk of major osteoporotic fracture or 3% risk of hip fracture.
• Long-term steroid use or another cause of accelerated loss.

For a woman with osteopenia (T-score between -1.0 and -2.5) and a low FRAX, the arithmetic is closer, and many physicians reasonably choose to monitor with a repeat DEXA in 12 to 24 months while she builds the non-drug side of her plan.

To weigh it with your physician, bring your DEXA, your FRAX if you have it, your dental plans, and your kidney numbers. Then ask:

• Which of my numbers is driving this recommendation, and what is my ten-year fracture risk?
• What is this medication expected to do to my T-score by my next scan?
• How long do you expect me to take it, and what would make you pause it?
• What symptoms would you want a same-day call about?
• I am adding a mechanical loading program; does that change anything in your plan?

Physicians across Austin and Georgetown hear that last question every week, and the answer is usually a straightforward yes, go.

What bisphosphonates cannot do, and what fills the gap

A bisphosphonate changes bone chemistry. It slows removal. It does not tell your skeleton where strength is needed, and it does nothing for the muscle, balance, and reaction time that decide whether a stumble becomes a fall. Roughly 1 in 3 adults over 65 falls each year, according to the CDC, and no tablet changes that number.

Bone is built to respond to strain above a threshold, roughly 4.2 times body weight in the research (Deere et al., 2012), a load walking and ordinary exercise never approach. Osteogenic loading reaches it by having you produce force against a device from your strongest range of motion, with no impact and a coach beside you, about 15 minutes once a week at our Austin and Georgetown centers. Force output is measured every session, so you see progress long before the next DEXA. Our session protocols are reviewed on an ongoing basis with the physicians who refer to us, and more than 100 Austin-area physicians do, with their patients staying on whatever they were prescribed. Nicole, an Austin member in her 60s who came to us with an osteoporosis diagnosis and a medication conversation on the table, saw her spine reclassified as no longer osteoporotic 15 months later; her case study has the numbers.

Among members who follow the weekly protocol and complete a follow-up DEXA (performed by independent imaging providers, never by us), 8 out of 10 see measurable improvement, with consistency and starting point as the biggest factors. If you want to see how the two sit together, read how OsteoStrong fits alongside osteoporosis treatment in Austin and how it works.

The bottom line

Fosamax and other bisphosphonates are worth the risk for most of the women who are prescribed them: the fractures they prevent outnumber the rare jaw and femur events by a wide margin when fracture risk is high. The oral rules protect your esophagus, dental coordination protects your jaw, and a physician-directed reassessment after 3 to 5 years keeps the duration risk in check. The closer your risk is to osteopenia with a low FRAX, the more the decision becomes a conversation rather than a default. Either way, the medication handles chemistry, and something else has to handle load.

Want to know where osteogenic loading fits beside your prescription? Book a free Bone Health Roadmap Call, bring your DEXA and your medication list, and we will walk through it with you.

This article is for general education and is not medical advice. Talk to your own doctor before starting, stopping, or changing any medication, supplement, or exercise program, especially if you have a diagnosis of osteopenia or osteoporosis.

Frequently asked questions